Literature DB >> 11795607

Consumers' attitudes and behavior toward prescription drug advertising.

Nithima Sumpradit1, Stuart W Fors, Laura McCormick.   

Abstract

OBJECTIVE: To explore how consumers' characteristics interact with direct-to-consumer advertising (DTCA) to influence 2 behaviors: information seeking and asking for prescription.
METHOD: A secondary data analysis was conducted using a subset of 1,102 consumers who responded to a 1998 national survey conducted by Prevention magazine.
RESULTS: Being afflicted with chronic conditions and having positive attitudes toward DTCA were associated with the consumers' willingness to talk with doctors about the advertised drugs. Consumers who asked for prescriptions tended to agree that DTCA made prescription drugs appear harmless and helped them make their own decision.
CONCLUSION: DTCA appears to have an influence on consumers' behavior.

Mesh:

Year:  2002        PMID: 11795607     DOI: 10.5993/ajhb.26.1.7

Source DB:  PubMed          Journal:  Am J Health Behav        ISSN: 1087-3244


  6 in total

1.  Do antidepressant advertisements educate consumers and promote communication between patients with depression and their physicians?

Authors:  Robert A Bell; Laramie D Taylor; Richard L Kravitz
Journal:  Patient Educ Couns       Date:  2010-02-21

2.  Direct-to-Consumer Advertising of Prescription Drugs and the Patient-Prescriber Encounter: A Systematic Review.

Authors:  Jessica T DeFrank; Nancy D Berkman; Leila Kahwati; Katherine Cullen; Kathryn J Aikin; Helen W Sullivan
Journal:  Health Commun       Date:  2019-04-11

3.  Cancer-related direct-to-consumer advertising: awareness, perceptions, and reported impact among patients undergoing active cancer treatment.

Authors:  Gregory A Abel; Harold J Burstein; Nathanael D Hevelone; Jane C Weeks
Journal:  J Clin Oncol       Date:  2009-08-03       Impact factor: 44.544

4.  A decade of controversy: balancing policy with evidence in the regulation of prescription drug advertising.

Authors:  Dominick L Frosch; David Grande; Derjung M Tarn; Richard L Kravitz
Journal:  Am J Public Health       Date:  2010-01       Impact factor: 9.308

5.  Measuring Exposure to Direct-to-Consumer Advertising-A Validation Study in the Context of Cancer-Related Treatment Advertising.

Authors:  Andy Sl Tan; Robert C Hornik
Journal:  Commun Methods Meas       Date:  2014-01-01

Review 6.  What do we know about communicating risk? A brief review and suggestion for contextualising serious, but rare, risk, and the example of cox-2 selective and non-selective NSAIDs.

Authors:  R Andrew Moore; Sheena Derry; Henry J McQuay; John Paling
Journal:  Arthritis Res Ther       Date:  2008-02-07       Impact factor: 5.156

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.